A multivariate analysis of Multiple Myeloma subtype plasma cells

被引:7
|
作者
Bonsignore, Martina [1 ]
Trusso, Sebastiano [2 ]
De Pasquale, Claudia [3 ]
Ferlazzo, Guido [3 ]
Allegra, Alessandro [4 ]
Innao, Vanessa [4 ]
Musolino, Caterina [4 ]
Franco, Domenico [5 ]
De Plano, Laura Maria [5 ]
Guglielmino, Salvatore Pietro Paolo [5 ]
Neri, Fortunato [1 ]
Fazio, Enza [1 ]
机构
[1] Univ Messina, Dept Math & Computat Sci, Phys Sci & Earth Sci, Messina, Italy
[2] CNR, Inst Chem Proc IPCF, Messina, Italy
[3] Univ Messina, Dept Human Pathol, Lab Immunol & Biotherapy, Messina, Italy
[4] Univ Messina, Dept Human Pathol Adulthood & Childhood Gaetano B, Div Hematol, Messina, Italy
[5] Univ Messina, Dept Chem Sci Biol Pharmaceut & Environm, Messina, Italy
关键词
Raman spectroscopy; PCA; Multiple Myeloma; Cell sorting; RAMAN-SPECTROSCOPY;
D O I
10.1016/j.saa.2021.119813
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Trusted methods for identifying different Multiple Myeloma (MM) cells and their biological diversity due to their immunophenotypic variety are often little detailed and difficult to find in literature. In this work, we show that micro-Raman spectroscopy can be used to highlight if there is a certain degree of distinction or correlation between the MM subtype plasmacells in relation to the cluster of differentiation (CD45 +/CD38+/CD138-) and (CD45-/CD38+/CD138+). After taking samples from the bone marrow of patients with Multiple Myeloma, the PCs were sorted by flow cytometry, selecting the most common CD of the disease, i.e. CD 45, CD38 and CD138. Some spectral differences are observed comparing the Raman spectra of the two set of samples investigated. To better define in which spectral regions there are greater differences and, therefore, to which biological contributions the changes refers, we also explored the principal component analysis (PCA) of the collected Raman data. The spectral variations between the different sorted cells have been highlighted by plotting loading vectors PC1 and PC2, which shows a net differentiation between the two set of cells. Ultimately, the differences shown by PCA have been associated with the spectral variations observed and explained in terms of changes of proteins and lipid contributions. Thus, the differentiation of Multiple Myeloma subtype plasma cells by confocal micro-Raman spectroscopy can be proposed as a diagnostic tool in the speeding up of cell identification, assessing the intracellular biochemical changes that take place in cancer cells. (c) 2021 Published by Elsevier B.V.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Clinical analysis of the prognostic value of ultrastructural abnormalities of plasma cells in patients with multiple myeloma
    Kurabayashi, H
    Kubota, K
    Tamura, J
    Naruse, T
    Murakami, H
    Tsuchiya, J
    ULTRASTRUCTURAL PATHOLOGY, 1998, 22 (06) : 439 - 442
  • [2] The 3D genome of plasma cells in multiple myeloma
    Kaiji Zhang
    Mengsi Chen
    Ming Chen
    Yue Wang
    Haibo Liu
    Yanju Li
    Xiaohong Guan
    Lihua Lei
    Li Tao
    Xiaoxiao Liu
    Dong He
    Xiaoli Fei
    Scientific Reports, 15 (1)
  • [3] Sclerostin is overexpressed by plasma cells from multiple myeloma patients
    Brunetti, Giacomina
    Oranger, Angela
    Mori, Giorgio
    Specchia, Giorgina
    Rinaldi, Erminia
    Curci, Paola
    Zallone, Alberta
    Rizzi, Rita
    Grano, Maria
    Colucci, Silvia
    SKELETAL BIOLOGY AND MEDICINE I, 2011, 1237 : 19 - 23
  • [4] PHAGOCYTIC PLASMA-CELLS IN A PATIENT WITH MULTIPLE-MYELOMA
    VANHAGEN, PM
    DELEEUW, K
    HAGEMEIJER, A
    LOWENBERG, B
    NETHERLANDS JOURNAL OF MEDICINE, 1995, 46 (01) : 25 - 29
  • [5] Prognostic significance of morphological assessment of plasma cells in multiple myeloma
    Al-Sahmani, M.
    Trnavska, I.
    Sevcikova, S.
    Antosova, M.
    Antosova, L.
    Kissova, J.
    Adam, Z.
    Pour, L.
    Nemec, P.
    Greslikova, H.
    Krejci, M.
    Zahradova, L.
    Bulikova, A.
    Penka, M.
    Hajek, R.
    NEOPLASMA, 2011, 58 (06) : 554 - 560
  • [6] Bone marrow angiogenesis and circulating plasma cells in multiple myeloma
    Kumar, S
    Witzig, TE
    Greipp, PR
    Rajkumar, SV
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (02) : 272 - 274
  • [7] IMMUNOPHENOTYPIC ANALYSIS OF LYMPHOCYTES AND MYELOMA CELLS IN PATIENTS WITH MULTIPLE-MYELOMA
    SHIMAZAKI, C
    FRIED, J
    PEREZ, AG
    SCHEINBERG, DA
    ATZPODIEN, J
    WANG, CY
    WISNIEWOLSKI, R
    CLARKSON, BD
    ACTA HAEMATOLOGICA, 1990, 83 (03) : 123 - 129
  • [8] Quantification of clonal circulating plasma cells in relapsed multiple myeloma
    Gonsalves, Wilson I.
    Morice, William G.
    Rajkumar, Vincent
    Gupta, Vinay
    Timm, Michael M.
    Dispenzieri, Angela
    Buadi, Francis K.
    Lacy, Martha Q.
    Singh, Preet P.
    Kapoor, Prashant
    Gertz, Morie A.
    Kumar, Shaji K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (04) : 500 - 505
  • [9] SIGNIFICANCE OF CIRCULATING PLASMA-CELLS IN MULTIPLE-MYELOMA
    ZANDECKI, M
    FACON, T
    PREUDHOMME, C
    CANIS, F
    IZYDORCZYK, V
    LOVI, V
    HAMMAD, M
    BAUTERS, F
    COSSON, A
    LEUKEMIA & LYMPHOMA, 1994, 14 (5-6) : 491 - 496
  • [10] NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
    Conticello, Concetta
    Giuffrida, Raffaella
    Adamo, Luana
    Anastasi, Gabriele
    Martinetti, Daniela
    Salomone, Edvige
    Colarossi, Cristina
    Amato, Gabriella
    Gorgone, Ausilia
    Romano, Alessandra
    Iannolo, Gioacchin
    De Maria, Ruggero
    Giustolisi, Rosario
    Gulisano, Massimo
    Di Raimondo, Francesco
    LEUKEMIA RESEARCH, 2011, 35 (01) : 52 - 60